Heterotopic pregnancy associated with assisted reproductive technology.
The incidence of heterotopic pregnancy has been reported to be 1 per 30,000 pregnancies. This incidence may be much higher in pregnancies associated with assisted reproductive technology. Intravaginal ultrasonography and the use of quantitative beta-subunit assays of human chorionic gonadotropin should allow early diagnosis and treatment.
['Abortion, Induced', 'Adult', 'Amniocentesis', 'Chorionic Gonadotropin/blood', 'Chorionic Gonadotropin, beta Subunit, Human', 'Down Syndrome/diagnosis', 'Female', 'Fertilization in Vitro', 'Fetal Diseases/diagnosis', 'Gamete Intrafallopian Transfer', 'Humans', 'Peptide Fragments/blood', 'Pregnancy', '*Pregnancy, Multiple', 'Pregnancy, Tubal/diagnosis/*etiology', 'Progesterone/blood', 'Reproductive Techniques/*adverse effects', 'Risk Factors', 'Ultrasonography']